IntelliPharmaCeutics Announces Second Quarter 2013 Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TORONTO, July 2, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and six months ended May 31, 2013. All dollar amounts referenced herein are in United States dollars unless otherwise noted.
Help employers find you! Check out all the jobs and post your resume.
TORONTO, July 2, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and six months ended May 31, 2013. All dollar amounts referenced herein are in United States dollars unless otherwise noted.
Help employers find you! Check out all the jobs and post your resume.